April 15, 2025 07:28 PM EDT
Pharma
FDA+

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

Max Bayer

Pharma Reporter

A se­nior CDC staffer lead­ing the agency’s re­sponse to the measles out­break in Texas said that agency is strug­gling to find the re­sources and per­son­nel …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times